AbbVie Inc (ABBV)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 3,716,000 | 7,197,000 | 7,066,000 | 7,530,000 | 6,250,000 | 8,003,000 | 10,450,000 | 9,023,000 | 13,477,000 | 14,783,000 | 14,071,000 | 14,051,000 | 12,989,000 | 7,211,000 | 6,023,000 | 4,167,000 | 3,398,000 | 7,979,000 | 7,480,000 | 8,980,000 |
| Revenue (ttm) | US$ in thousands | 56,334,000 | 55,533,000 | 55,000,000 | 54,403,000 | 54,318,000 | 55,138,000 | 56,023,000 | 56,741,000 | 58,054,000 | 57,819,000 | 57,349,000 | 56,725,000 | 56,197,000 | 55,169,000 | 53,729,000 | 50,195,000 | 45,804,000 | 40,650,000 | 36,227,000 | 34,057,000 |
| Pretax margin | 6.60% | 12.96% | 12.85% | 13.84% | 11.51% | 14.51% | 18.65% | 15.90% | 23.21% | 25.57% | 24.54% | 24.77% | 23.11% | 13.07% | 11.21% | 8.30% | 7.42% | 19.63% | 20.65% | 26.37% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $3,716,000K ÷ $56,334,000K
= 6.60%
AbbVie Inc's pretax margin has shown fluctuations over the given period. At the end of December 2024, the pretax margin stood at a relatively low 6.60%, indicating that for every dollar of revenue generated, the company retained 6.60 cents before accounting for taxes. This was a significant decline compared to the pretax margin of 25.57% at the end of September 2022, which was the highest point during the period.
The pretax margin experienced a downward trend from September 2022 to December 2024, with occasional increases and decreases. The company's profitability before taxes peaked in March 2023 at 18.65% but then declined gradually in subsequent quarters. AbbVie Inc faced challenges in maintaining its pretax margin towards the end of the analyzed period, with margins hovering around the 12-13% range for most of 2024.
Overall, AbbVie Inc's pretax margin performance suggests fluctuations in its operational efficiency and cost management strategies, impacting its profitability before accounting for taxes. Further analysis of the company's operating expenses, revenue trends, and potential macroeconomic factors influencing profitability could provide deeper insights into the dynamics behind these fluctuations.
Peer comparison
Dec 31, 2024